FDA — authorised 13 March 2013
- Marketing authorisation holder: NAVIDEA BIOPHARMS
- Status: approved
🇺🇸 Lymphoseek Kit in United States
FDA authorised Lymphoseek Kit on 13 March 2013
Marketing authorisations
FDA — authorised 13 March 2013
- Application: NDA202207
- Marketing authorisation holder: CARDINAL HEALTH 414
- Local brand name: LYMPHOSEEK KIT
- Indication: INJECTABLE — INJECTION
- Status: approved
Lymphoseek Kit in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Lymphoseek Kit approved in United States?
Yes. FDA authorised it on 13 March 2013; FDA authorised it on 13 March 2013.
Who is the marketing authorisation holder for Lymphoseek Kit in United States?
NAVIDEA BIOPHARMS holds the US marketing authorisation.